R R

What Is Mucous Membrane Pemphigoid?

Mucous membrane pemphigoid (MMP) is a chronic autoimmune blistering disease that targets mucosal surfaces, including the conjunctiva. Autoantibodies attack components of the basement membrane zone, leading to subepithelial blistering and progressive scarring. In the eye, this process is often called ocular cicatricial pemphigoid. Over time, conjunctival fibrosis, symblepharon, entropion, and severe dry eye can develop. Without prompt systemic treatment, MMP can threaten both comfort and vision.

Link to This Resource Page

Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.

To display this...

What Is Mucous Membrane Pemphigoid?

Mucous membrane pemphigoid (MMP) is a chronic autoimmune blistering disease that targets mucosal surfaces, including the conjunctiva. Autoantibodies attack components of the basement membrane zone, leading to subepithelial blistering and progressive scarring. In the eye, this process is often called ocular cicatricial pemphigoid. Over time, conjunctival fibrosis, symblepharon, entropion, and severe dry eye can develop. Without prompt systemic treatment, MMP can threaten both comfort and vision.

read more about mucous membrane pemphigoid ...

Copy this HTML:

Copy HTML Copied!

Pathophysiology and Systemic Involvement

In MMP, circulating and tissue bound autoantibodies react with structural proteins in the basement membrane of mucous membranes. Complement activation and inflammatory cell recruitment cause tissue separation and blister formation. The healing process leaves fibrosis and distortion rather than normal architecture. Oral, nasal, pharyngeal, laryngeal, and genital mucosa can be involved along with the eyes. Severity varies widely, from mild localized disease to widespread scarring and airway compromise.

Ocular Features and Complications

Early ocular signs include chronic redness, burning, and recurrent conjunctival inflammation that may resemble allergic or nonspecific conjunctivitis. As scarring progresses, the fornices shorten, symblepharon bands form between bulbar and tarsal conjunctiva, and the lid margin rotates inward. Trichiasis, entropion, and meibomian gland loss contribute to severe ocular surface disease and keratopathy. Corneal complications such as persistent epithelial defects, ulceration, and vascularization can lead to vision loss.

How Is Mucous Membrane Pemphigoid Diagnosed?

Diagnosis rests on clinical suspicion plus histopathologic and immunopathologic confirmation. A conjunctival or oral biopsy is taken from an active lesion or perilesional area. Routine histology shows subepithelial clefting, while direct immunofluorescence reveals linear deposition of immunoglobulin and complement along the basement membrane zone. Serologic tests can detect circulating autoantibodies in some patients. Early involvement of dermatology, rheumatology, and otolaryngology helps document all affected sites.

How Is Mucous Membrane Pemphigoid Managed?

Treatment usually requires systemic immunosuppression to control inflammation and limit scarring. Options include dapsone, systemic corticosteroids, and steroid sparing agents such as azathioprine, mycophenolate, cyclophosphamide, or biologics, guided by disease severity and comorbidities. Topical lubricants, corticosteroids, and calcineurin inhibitors support the ocular surface but do not replace systemic therapy. Lid surgery, amniotic membrane grafts, and mucous membrane grafts are used to manage structural problems and protect the cornea once inflammation is controlled. Lifelong follow up is common because relapses can occur.

FAQs About Mucous Membrane Pemphigoid

Is ocular cicatricial pemphigoid the same as mucous membrane pemphigoid?

Ocular cicatricial pemphigoid refers to eye involvement in MMP. It is part of the same disease process but emphasizes conjunctival scarring and ocular complications.

Can eye drops alone control mucous membrane pemphigoid?

Topical therapy helps symptoms but does not stop the autoimmune attack. Most patients with active disease need systemic treatment to slow or halt scarring.

Will mucous membrane pemphigoid go into remission?

Some patients achieve prolonged quiescence with treatment, while others have relapsing disease. Regular monitoring is needed even when symptoms improve.

Are family members at risk if one person has MMP?

MMP is not directly contagious. There is some association with autoimmune traits, but most relatives never develop the disease.

References

EyeWiki. “Ocular Cicatricial Pemphigoid.” https://eyewiki.org/Ocular_Cicatricial_Pemphigoid?281344160936135†L108-L160?

StatPearls. “Ocular Pemphigoid.” https://www.ncbi.nlm.nih.gov/books/NBK554595/?765949191069651†L101-L148?

University of Utah Health. “Ocular Cicatricial Pemphigoid.” https://healthcare.utah.edu/moran/ophthalmology/ocular-cicatricial-pemphigoid?966190238187299†L53-L63?

Merck Manual. “Ocular mucous membrane pemphigoid.” https://www.merckmanuals.com/home/eye-disorders/conjunctival-and-scleral-disorders/ocular-mucous-membrane-pemphigoid?442155466878091†L92-L123?

Autoimmune Association. “Ocular cicatricial pemphigoid: symptoms & causes.” https://autoimmune.org/disease-information/ocular-cicatricial-pemphigoid?356383521091644†L90-L110?

""